- Home
- HUM vs IQV Comparison
HUM vs IQV Comparison
Compare HUM & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUM
- IQV
- Stock Information
- Founded
- HUM 1961
- IQV 1982
- Country
- HUM United States
- IQV United States
- Employees
- HUM N/A
- IQV N/A
- Industry
- HUM Medical Specialities
- IQV Biotechnology: Commercial Physical & Biological Resarch
- Sector
- HUM Health Care
- IQV Health Care
- Exchange
- HUM Nasdaq
- IQV Nasdaq
- Market Cap
- HUM 32.0B
- IQV 31.6B
- IPO Year
- HUM 1993
- IQV 2013
- Fundamental
- Price
- HUM $265.80
- IQV $174.35
- Analyst Decision
- HUM Hold
- IQV Strong Buy
- Analyst Count
- HUM 21
- IQV 18
- Target Price
- HUM $289.05
- IQV $248.72
- AVG Volume (30 Days)
- HUM 1.3M
- IQV 1.5M
- Earning Date
- HUM 04-30-2025
- IQV 05-01-2025
- Dividend Yield
- HUM 1.34%
- IQV N/A
- EPS Growth
- HUM N/A
- IQV 2.74
- EPS
- HUM 9.98
- IQV 7.49
- Revenue
- HUM $117,761,000,000.00
- IQV $15,405,000,000.00
- Revenue This Year
- HUM $7.27
- IQV $4.25
- Revenue Next Year
- HUM $1.45
- IQV $6.17
- P/E Ratio
- HUM $26.52
- IQV $23.21
- Revenue Growth
- HUM 10.71
- IQV 2.81
- 52 Week Low
- HUM $213.31
- IQV $169.11
- 52 Week High
- HUM $406.46
- IQV $252.88
- Technical
- Relative Strength Index (RSI)
- HUM 50.56
- IQV 35.36
- Support Level
- HUM $260.75
- IQV $169.37
- Resistance Level
- HUM $268.24
- IQV $188.39
- Average True Range (ATR)
- HUM 6.87
- IQV 4.83
- MACD
- HUM 0.43
- IQV -0.79
- Stochastic Oscillator
- HUM 60.39
- IQV 25.16
About HUM Humana Inc.
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
About IQV IQVIA Holdings Inc.
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.